MEDIF

Medipharm Labs Corp

As international medical cannabis demand surges, a shift in global regulatory landscapes is creating a distinct advantage for producers with pharmaceutical-grade infrastructure. While the domestic Canadian market has faced persistent headwinds from pricing compression and tax burdens, the opening of major European and South American markets has redirected the sector’s growth trajectory toward higher-margin export channels. Germany's patient market has grown significantly following regulatory changes that simplified prescribing, while Canadian exports have seen a promising ...

As international medical cannabis demand surges, a shift in global regulatory landscapes is creating a distinct advantage for producers with pharmaceutical-grade infrastructure. While the domestic Canadian market has faced persistent headwinds from pricing compression and tax burdens, the opening of major European and South American markets has redirected the sector’s growth trajectory toward higher-margin export channels. Germany's patient market has grown significantly following regulatory changes that simplified prescribing, while Canadian exports have seen a promising ...